Cart
sales@molnova.com
Sitaxsentan
CAS No. 184036-34-8
Sitaxsentan( IPI-1040 | Sitaxentan | TBC-11251 )
Catalog No. M12843 CAS No. 184036-34-8
A potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 739 | In Stock |
|
| 10MG | 950 | In Stock |
|
| 25MG | 1235 | In Stock |
|
| 50MG | 1488 | In Stock |
|
| 100MG | 1860 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3720 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSitaxsentan
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM.
-
DescriptionA potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM; dispalys >5,000-fold selectivity over ETB receptors; inhibits ET1-induced stimulation of phosphoinositide turnover with Ki of 0.686 nM, and pA2 of 8.0; excellent PK profile and oral bioavailability.Hypertension Withdrawn.
-
In Vitro——
-
In Vivo——
-
SynonymsIPI-1040 | Sitaxentan | TBC-11251
-
PathwayGPCR/G Protein
-
TargetEndothelin Receptor
-
RecptorEndothelin Receptor
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number184036-34-8
-
Formula Weight454.9045
-
Molecular FormulaC18H15ClN2O6S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2
-
Chemical Name3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wu C, et al. J Med Chem. 1997 May 23;40(11):1690-7.
2. Wanebo JE, et al. Neurosurgery. 1998 Dec;43(6):1409-17; discussion 1417-8.
3. Tilton RG, et al. Pulm Pharmacol Ther. 2000;13(2):87-97.
molnova catalog
related products
-
Ambrisentan
Ambrisentan (BSF 208075;LU 208075) is a highly selective antagonist of the endothelin-1 type A receptor (ETA) for use in the treatment of pulmonary hypertension.
-
Carperitide acetate
Carperitide acetateis a 28-amino acid hormone. Carperitide acetate is normally produced and secreted by the human heart in response to cardiac injury and mechanical stretch. Carperitide acetate inhibits endothelin-1 secretion in a dose-dependent way.
-
Ro 46-2005
Ro 46-2005 is the first synthetic orally active nonpeptide antagonist of endothelin receptor with equipotent potency (IC50=0.2-0.5 uM) for ETA and ETB.
